Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Autoinjector Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global autoinjector market reached a value of US$ 1.65 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 4.39 Billion by 2027, exhibiting a growth rate (CAGR) of 16.70% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Autoinjectors are self-injectable devices that help deliver drugs via the subcutaneous or intramuscular route. They offer several advantages, such as dosage accuracy and improved patient compliance, and help reduce needle phobia of patients, lower needlestick injuries resulting from a hidden needle, and increase the convenience and efficiency of healthcare professionals. They are widely used during emergency conditions, such as anaphylaxis, migraine, status epilepticus, psoriasis, diabetes, multiple sclerosis, and rheumatoid arthritis. As a result, autoinjectors find extensive applications in hospitals, clinics, and home care centers across the globe.

 

 
 

www.imarcgroup.com

Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

Autoinjector Market Trends:

At present, there is a rise in the prevalence of arthritis, asthma, cancer, chronic obstructive pulmonary disease (COPD) and Alzheimer’s disease. This, along with the growing need for self-administrating medicines, represents one of the key factors driving the market. Moreover, governments of several countries are undertaking initiatives to promote the use of autoinjectors in schools. This, coupled with the increasing awareness among individuals about the benefits of autoinjectors, is propelling the growth of the market. In addition, key market players are extensively investing in research and development (R&D) activities to develop simple, cost-effective, and new technology-based autoinjectors for treating rheumatoid arthritis and multiple sclerosis. Besides this, the rising adoption of targeted therapies to alter proteins within cancer cells and prevent the formation of new blood vessels in the tumor is offering lucrative growth opportunities to industry investors. Additionally, the burgeoning healthcare industry around the world is bolstering the growth of the market. Some of the other factors inducing growth are the increasing number of regulatory approvals, technological advancements, patent expiry of biologics and the availability of generic versions of autoinjectors.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global autoinjector market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type, application and end user.

Breakup by Type:

 

 
 

www.imarcgroup.com

Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

  • Disposable Autoinjectors 
  • Reusable Autoinjectors
     

Breakup by Application:

  • Rheumatoid Arthritis
  • Anaphylaxis
  • Multiple Sclerosis
  • Others
     

Breakup by End User:

  • Home Care Settings
  • Hospitals and Clinics
     

Breakup by Region:

 

 
 

www.imarcgroup.com

To get more information on the regional analysis of this market, Request Sample

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Amgen Inc., Antares Pharma Inc., Becton Dickinson and Company, Bristol-Myers Squibb Company, Eisai Co. Ltd., Eli Lilly and Company, Haselmeier GmbH (Sulzer Ltd.), Johnson & Johnson, Mylan N.V. (Viatris Inc.), Novartis AG, SHL Medical AG, Teva Pharmaceutical Industries Ltd. and Ypsomed Holding AG.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
    Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Type, Application, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Amgen Inc., Antares Pharma Inc., Becton Dickinson and Company, Bristol-Myers Squibb Company, Eisai Co. Ltd., Eli Lilly and Company, Haselmeier GmbH (Sulzer Ltd.), Johnson & Johnson, Mylan N.V. (Viatris Inc.), Novartis AG, SHL Medical AG, Teva Pharmaceutical Industries Ltd. and Ypsomed Holding AG.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

1    Preface
2    Scope and Methodology
    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction
    4.1    Overview
    4.2    Key Industry Trends
5    Global Autoinjector Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Type 
    6.1    Disposable Autoinjectors 
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Reusable Autoinjectors 
        6.2.1 Market Trends
        6.2.2 Market Forecast
7    Market Breakup by Application 
    7.1    Rheumatoid Arthritis
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Anaphylaxis
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Multiple Sclerosis
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Others
        7.4.1 Market Trends
        7.4.2 Market Forecast
8    Market Breakup by End User
    8.1    Home Care Settings
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Hospitals and Clinics 
        8.2.1 Market Trends
        8.2.2 Market Forecast
9    Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10    SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11    Value Chain Analysis
12    Porters Five Forces Analysis
    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13    Price Analysis
14    Competitive Landscape
    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Amgen Inc.
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
           14.3.1.3 Financials
           14.3.1.4 SWOT Analysis
        14.3.2    Antares Pharma Inc.
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
           14.3.2.3 Financials
           14.3.2.4 SWOT Analysis
        14.3.3    Becton Dickinson and Company
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
           14.3.3.3 Financials
           14.3.3.4 SWOT Analysis
        14.3.4    Bristol-Myers Squibb Company
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
           14.3.4.3 Financials
           14.3.4.4 SWOT Analysis
        14.3.5    Eisai Co. Ltd.
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
           14.3.5.3 Financials
           14.3.5.4 SWOT Analysis
        14.3.6    Eli Lilly and Company
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
           14.3.6.3 Financials
           14.3.6.4 SWOT Analysis
        14.3.7    Haselmeier GmbH (Sulzer Ltd.)
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
        14.3.8    Johnson & Johnson
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
           14.3.8.3 Financials
           14.3.8.4 SWOT Analysis
        14.3.9    Mylan N.V. (Viatris Inc.)
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio
        14.3.10    Novartis AG
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio
           14.3.10.3 Financials
           14.3.10.4 SWOT Analysis
        14.3.11    SHL Medical AG
           14.3.11.1 Company Overview
           14.3.11.2 Product Portfolio
        14.3.12    Teva Pharmaceutical Industries Ltd.
           14.3.12.1 Company Overview
           14.3.12.2 Product Portfolio
           14.3.12.3 Financials
           14.3.12.4 SWOT Analysis
        14.3.13    Ypsomed Holding AG
           14.3.13.1 Company Overview
           14.3.13.2 Product Portfolio
           14.3.13.3 Financials
           14.3.13.4 SWOT Analysis

List of Figures

Figure 1: Global: Autoinjector Market: Major Drivers and Challenges
Figure 2: Global: Autoinjector Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Autoinjector Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Autoinjector Market: Breakup by Type (in %), 2021
Figure 5: Global: Autoinjector Market: Breakup by Application (in %), 2021
Figure 6: Global: Autoinjector Market: Breakup by End User (in %), 2021
Figure 7: Global: Autoinjector Market: Breakup by Region (in %), 2021
Figure 8: Global: Autoinjector (Disposable Autoinjectors) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Autoinjector (Disposable Autoinjectors) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Autoinjector (Reusable Autoinjectors) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Autoinjector (Reusable Autoinjectors) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Autoinjector (Rheumatoid Arthritis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Autoinjector (Rheumatoid Arthritis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Autoinjector (Anaphylaxis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Autoinjector (Anaphylaxis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Autoinjector (Multiple Sclerosis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Autoinjector (Multiple Sclerosis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Autoinjector (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Autoinjector (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Autoinjector (Home Care Settings) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Autoinjector (Home Care Settings) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Autoinjector (Hospitals and Clinics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Autoinjector (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: North America: Autoinjector Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: North America: Autoinjector Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: United States: Autoinjector Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: United States: Autoinjector Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Canada: Autoinjector Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Canada: Autoinjector Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Asia-Pacific: Autoinjector Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Asia-Pacific: Autoinjector Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: China: Autoinjector Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: China: Autoinjector Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Japan: Autoinjector Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Japan: Autoinjector Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: India: Autoinjector Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: India: Autoinjector Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: South Korea: Autoinjector Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: South Korea: Autoinjector Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: Australia: Autoinjector Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: Australia: Autoinjector Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: Indonesia: Autoinjector Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: Indonesia: Autoinjector Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Others: Autoinjector Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Others: Autoinjector Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Europe: Autoinjector Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Europe: Autoinjector Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Germany: Autoinjector Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Germany: Autoinjector Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: France: Autoinjector Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: France: Autoinjector Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: United Kingdom: Autoinjector Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: United Kingdom: Autoinjector Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: Italy: Autoinjector Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: Italy: Autoinjector Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: Spain: Autoinjector Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: Spain: Autoinjector Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Russia: Autoinjector Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Russia: Autoinjector Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Others: Autoinjector Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Others: Autoinjector Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Latin America: Autoinjector Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Latin America: Autoinjector Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Brazil: Autoinjector Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Brazil: Autoinjector Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Mexico: Autoinjector Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Mexico: Autoinjector Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Others: Autoinjector Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Others: Autoinjector Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Middle East and Africa: Autoinjector Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Middle East and Africa: Autoinjector Market: Breakup by Country (in %), 2021
Figure 72: Middle East and Africa: Autoinjector Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Global: Autoinjector Industry: SWOT Analysis
Figure 74: Global: Autoinjector Industry: Value Chain Analysis
Figure 75: Global: Autoinjector Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Autoinjector Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Autoinjector Market Forecast: Breakup by Type (in Million US$), 2022-2027
Table 3: Global: Autoinjector Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 4: Global: Autoinjector Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 5: Global: Autoinjector Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Autoinjector Market: Competitive Structure
Table 7: Global: Autoinjector Market: Key Players


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Key Questions Answered in This Report

The global autoinjector market was valued at US$ 1.65 Billion in 2021.

We expect the global autoinjector market to exhibit a CAGR of 16.70% during 2022-2027.

The high prevalence of several chronic ailments, along with the growing prominence of self-
administrative medicines, is primarily driving the global autoinjector market.

The sudden outbreak of the COVID-19 pandemic has led to the rising demand for autoinjectors to
self-inject drugs for treating various emergency cases and reducing the risk of the coronavirus
infection upon hospital visits or interaction with healthcare professionals.

Based on the type, the global autoinjector market can be categorized into disposable autoinjectors
and reusable autoinjectors, where disposable autoinjectors currently exhibit clear dominance in the
market.

Based on the application, the global autoinjector market has been segmented into rheumatoid
arthritis, anaphylaxis, multiple sclerosis, and others. Among these, anaphylaxis represents the largest
market share.

Based on the end user, the global autoinjector market can be bifurcated into home care settings and
hospitals and clinics. Currently, home care settings account for the majority of the total market
share.

On a regional level, the market has been classified into North America, Europe, Asia-Pacific, Middle
East and Africa, and Latin America, where North America currently dominates the global market.

Some of the major players in the global autoinjector market include Amgen Inc., Antares Pharma
Inc., Becton Dickinson and Company, Bristol-Myers Squibb Company, Eisai Co. Ltd., Eli Lilly and
Company, Haselmeier GmbH (Sulzer Ltd.), Johnson & Johnson, Mylan N.V. (Viatris Inc.), Novartis AG,
SHL Medical AG, Teva Pharmaceutical Industries Ltd., and Ypsomed Holding AG.

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Related Report

Peripheral Vascular Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Read More

Vascular Grafts Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Read More

Operating Room Equipment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Read More

Intraoperative Neuromonitoring (IONM) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Read More

Neurology Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Read More

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )

Drop us an email at

sales@imarcgroup.com

Social Links